beta-lactams has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegria, W; Bixby, DL; Gregg, KS; Marini, BL; Nagel, J; Perissinotti, A | 1 |
| Crawford, R; Hobbs, ALV; Hobbs, DA; Perkins, NB | 1 |
2 other study(ies) available for beta-lactams and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute | 2022 |
Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute; Retrospective Studies | 2022 |